Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Neil Herskowitz currently holds 145 shares of Checkpoint Therapeutics, Inc. (CKPT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Neil Herskowitz has been a net buyer of CKPT stock. They have purchased $453.0K and sold $237 worth of shares.
Neil Herskowitz's most recent insider trade was on Dec 30, 2025, when they sold 247 shares at $0.96 per share.
Neil Herskowitz serves as Executive at Checkpoint Therapeutics, Inc. (CKPT). They have executed 71 insider transactions totaling $453.3K over their tenure at the company.
Neil Herskowitz holds the position of Executive at Checkpoint Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 21 years and currently hold a stake valued at $0.
Neil Herskowitz has shown a buying trading pattern, with $453.0K in total purchases and $237 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Neil Herskowitz was on Feb 25, 2020, when they purchased $93.1K worth of ATXI shares. This transaction involved 10,000 shares at $9.31 per share.
Neil Herskowitz currently owns 145 shares of Checkpoint Therapeutics, Inc. (CKPT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Neil Herskowitz's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Neil Herskowitz has 71 Form 4 filings on record as an insider at Checkpoint Therapeutics, Inc..
Set alerts for Neil Herskowitz and 40,000+ other insiders.